HLT, Inc. is sponsoring the RADIANT clinical study for patients with severe aortic stenosis. This study evaluates an investigational Transcatheter Aortic Valve Replacement (TAVR) procedure. The purpose of the study is to evaluate the safety and performance of the Meridian® Valve in patients with severe aortic stenosis who are at high risk for aortic valve replacement surgery.

To find out more about this clinical trial or to find out if you qualify, for the United States go to www.clinicaltrials.gov.us and for Canada go to: www.clincialtrials.gov